PGIM India Healthcare Growth Direct Plan
SIP amount
Min. ₹1,000
Lumpsum amount
Min. ₹5,000

PGIM India Healthcare Growth Direct Plan

NAV
₹9.9700
-1.09%
(16 Dec)
AUM
100 Cr
TER
0.66%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+13.4%
+4.0%
+1.7%
+1.1%
+0.4%
3Y
+29.7%
+28.4%
+29.1%
+28.3%
NA
5Y
NA
+18.9%
+24.8%
+28.3%
NA
ALL
+27.7%
+21.7%
+18.0%
+16.8%
-0.3%
VOL
14.4%
15.2%
16.2%
19.6%
13.1%
TER
1.0%
1.0%
0.5%
0.9%
0.7%
AUM
₹3,073 Cr
₹6,460 Cr
₹8,189 Cr
₹1,445 Cr
₹100 Cr
INFO
1.92
1.43
1.11
0.85
-0.02
See fund holdings as of 30th Nov
Top holdings
Sun Pharmaceuticals Industries Ltd
11.7%
Divi's Laboratories Ltd
10.0%
Max Healthcare Institute Ltd Ordinary Shares
7.2%
Aster DM Healthcare Ltd Ordinary Shares
6.2%
Dr Reddy's Laboratories Ltd
6.0%
J.B. Chemicals & Pharmaceuticals Ltd
5.1%
Mankind Pharma Ltd
4.6%
Rubicon Research Ltd
4.3%
Ajanta Pharma Ltd
3.9%
Abbott India Ltd
3.6%
Top industry exposure
Healthcare
90.5%
Financial Services
4.7%
Basic Materials
2.8%
Other information
Minimum SIP
₹1,000
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
25%
Lock-in period
-
Exit load
• 0.5% for redemption within 90 days
Fund objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns
Fund manager(s)
Puneet Pal
Anandha Padmanabhan Anjeneyan
Utsav Mehta
Vivek Sharma

FAQs